Related Experiment Videos
[Hypertension and multimetabolic syndrome]
1Belgyógyászati Osztály, Országos Korányi Tbc és Pulmonológiai Intézet, Budapest.
Orvosi Hetilap
|February 20, 1993
Summary
Multi-metabolic syndrome, characterized by obesity and hypertension, affects 65% of patients. Early diagnosis and prevention are crucial for mitigating risks of type 2 diabetes and atherosclerosis.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Cardiovascular Health
Context:
- Obesity, particularly android-type, and hypertension are significant public health concerns.
- Multi-metabolic syndrome represents a cluster of conditions increasing cardiovascular and diabetes risk.
- Understanding the prevalence and components of this syndrome is vital for preventative strategies.
Purpose:
- To investigate the occurrence and characteristics of multi-metabolic syndrome in patients with android obesity and hypertension.
- To assess the prevalence of dyslipidemia, hyperinsulinemia, and impaired carbohydrate metabolism within this patient group.
- To explore the relationship between glucose and insulin responses as an indicator of insulin resistance.
Summary:
- A study of 31 patients with android obesity and hypertension found multi-metabolic syndrome in 65% of cases.
- Key findings included dyslipidemia (22 cases), hyperinsulinemia (20 cases), and impaired carbohydrate metabolism (14 cases).
- A negative correlation between glucose and insulin responses suggested insulin resistance, with no significant sex-based differences in metabolic parameters.
Impact:
- Multi-metabolic syndrome is identified as a precursor to type 2 diabetes mellitus and atherosclerosis.
- The study highlights that approximately two-thirds of affected patients could be identified through screening.
- Emphasizes the critical need for early diagnosis and preventative interventions to manage this complex metabolic condition.